source
- CAR T therapy moves from cancer to autoimmune disease, leveraging oncology safety lessonsCell therapy that transformed treatment of blood cancers is now being tested for autoimmune disorders, according to a recent opinion piece. Early cancer trials showed high complete response rates…
- Genentech doubles down on ADC-resistant cancers with $1B DualityBio pactRoche’s Genentech is paying DualityBio $45 million upfront for rights to antibody-drug conjugates (ADCs) designed for the growing pool of patients who progress after treatment with the modality. Th…Fierce Biotech · 8h ago↗ source
- AstraZeneca and Amgen report positive Phase 3 results for Tezspire in eosinophilic esophagitis